Anika Therapeutics (ANIK) Competitor Comparison
We are evaluating the key criteria listed to compare Anika Therapeutics (ANIK) against its competitors in the Biotechnology industry.
Market Capitalization
187 / 368Gross Profits
46 / 278Total Revenue
67 / 300EBITDA
105 / 337Free Cashflow
80 / 352Quick Ratio
234 / 357Earnings per Share
325 / 359Dividend yield
0 / 6Total Cash
243 / 358Performance 3 years
178 / 368Performance 5 years
214 / 368Performance 10 years
160 / 368Linearity 3 years
106 / 368Linearity 5 years
168 / 368Linearity 10 years
79 / 368Total Rank
16 / 368Dividend Rank
27 / 368Valuation Rank
8 / 368Piotroski Rank
14 / 368Muliplier Rank
65 / 368Total Cash - ANIK ranking 243 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.